Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Expedia Group Inc (EXPE) vs ResMed Inc. (RMD) Price & Performance

Expedia Group IncTrade
ResMed Inc.Trade

Price performance (Past 24H)

Key statistics

Expedia Group Inc vs ResMed Inc. — how do they compare? Expedia Group Inc trades at $264.64 (market cap $32.06B), while ResMed Inc. trades at $202.22 (market cap $28.80B). The key difference: Expedia Group Inc and ResMed Inc. are close in size by market cap, and ResMed Inc. pays the higher dividend (1.21%). Which is the better fit depends on your goals.

EXPERMD
Market Cap
$32.06B$28.80B
Sector
Consumer CyclicalHealth
52-Week High
$301.31$293.73
52-Week Low
$178.06$182.82
Enterprise Value
$30.97B$27.99B
Dividend Yield
0.66%1.21%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Expedia Group Inc

No Aura AI signal available yet.

ResMed Inc.

ResMed (RMD) trades at $196.37, up 1.74% with strong fundamental performance including 27.44% net margins and consistent earnings beats. The company recently sold its MatrixCare business for $490 million to sharpen focus on core sleep and respiratory care markets. Technical indicators show bearish momentum despite oversold RSI conditions, while fundamentals demonstrate robust revenue growth from $5.15B to projected $5.5B in 2026.

RMD presents a compelling growth story with 40% analyst buy ratings and $245.88 consensus target suggesting 25% upside. Key risks include competitive pressures in medical technology and execution of strategic refocusing. The stock's current valuation at 19.15 P/E appears reasonable given earnings momentum and market leadership in sleep apnea treatment.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Expedia Group Inc

Expedia is the world's largest online travel agency by bookings, offering services for lodging (75% of total 2021 sales), air tickets (3%), rental cars, cruises, in-destination, and other (15%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, including Expedia.com, Hotels.com, Travelocity, Orbitz, Wotif, AirAsia, and Vrbo. It has also expanded into travel media with the acquisition of Trivago. Transaction fees for online bookings account for the bulk of sales and profits.

Read more on EXPE

About ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Read more on RMD